Multiple sclerosis patients and COVID-19

Coronavirus disease 2019 (COVID-19) is now a major issue for all fields of medicine. Due to the higher mortality rate among patients with chronic diseases, it has also caused concern in patients with multiple sclerosis (MS), who in addition are often receiving immunosuppressive drugs. The aim of thi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Egyptian Journal of Neurology, Psychiatry and Neurosurgery Psychiatry and Neurosurgery, 2021-03, Vol.57 (1), p.43-43, Article 43
Hauptverfasser:	Mado, Hubert, Adamczyk-Sowa, Monika
Format:	Artikel
Sprache:	eng
Schlagworte:	Coronaviruses COVID-19 DMT Letter to the Editor Medicine Medicine & Public Health Multiple sclerosis Neurology Neurosurgery Psychiatry SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Coronavirus disease 2019 (COVID-19) is now a major issue for all fields of medicine. Due to the higher mortality rate among patients with chronic diseases, it has also caused concern in patients with multiple sclerosis (MS), who in addition are often receiving immunosuppressive drugs. The aim of this article is to discuss what is currently known about the severity of COVID-19 in MS patients.
ISSN:	1110-1083 1687-8329 1687-8329
DOI:	10.1186/s41983-021-00287-3